392 related articles for article (PubMed ID: 10559090)
1. Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions.
Hua CC; Chang LC; Chen YC; Chang SC
Chest; 1999 Nov; 116(5):1292-6. PubMed ID: 10559090
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates.
Chung CL; Chen CH; Sheu JR; Chen YC; Chang SC
Chest; 2005 Aug; 128(2):690-7. PubMed ID: 16100155
[TBL] [Abstract][Full Text] [Related]
3. Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions.
Lin FC; Chen YC; Chen FJ; Chang SC
Clin Immunol; 2005 Aug; 116(2):166-73. PubMed ID: 15897010
[TBL] [Abstract][Full Text] [Related]
4. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion.
Chung CL; Chen YC; Chang SC
Chest; 2003 Apr; 123(4):1188-95. PubMed ID: 12684310
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Cytokine Levers in Pleural Effusions of Tuberculous Pleurisy and Tuberculous Empyema.
Yang L; Hu YJ; Li FG; Chang XJ; Zhang TH; Wang ZT
Mediators Inflamm; 2016; 2016():3068103. PubMed ID: 27034588
[TBL] [Abstract][Full Text] [Related]
6. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory cytokines, fibrinolytic system enzymes, and biochemical indices in children with infectious para-pneumonic effusions.
Chiu CY; Wong KS; Huang JL; Tasi MH; Lin TY; Hsieh SY
Pediatr Infect Dis J; 2008 Aug; 27(8):699-703. PubMed ID: 18664985
[TBL] [Abstract][Full Text] [Related]
8. Repeated thoracenteses affect proinflammatory cytokines, vascular endothelial growth factor, and fibrinolytic activity in pleural transudates.
Chung CL; Yeh CY; Sheu JR; Chen YC; Chang SC
Am J Med Sci; 2007 Dec; 334(6):452-7. PubMed ID: 18091367
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions.
Momi H; Matsuyama W; Inoue K; Kawabata M; Arimura K; Fukunaga H; Osame M
Respir Med; 2002 Oct; 96(10):817-22. PubMed ID: 12412982
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
Hamed EA; El-Noweihi AM; Mohamed AZ; Mahmoud A
Respirology; 2004 Mar; 9(1):81-6. PubMed ID: 14982607
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion.
Orphanidou D; Gaga M; Rasidakis A; Dimakou K; Toumbis M; Latsi P; Pandalos J; Christacopoulou J; Jordanoglou J
Respir Med; 1996 Feb; 90(2):95-8. PubMed ID: 8730328
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions.
Al-Aarag AH; Kamel MH; Abdelgawad ER; Abo-Youssef SM; Moussa HH; Elnaggar ME; Hendy RM; Diab KA
BMC Pulm Med; 2019 Jun; 19(1):114. PubMed ID: 31238901
[TBL] [Abstract][Full Text] [Related]
13. Assay of pleural fluid interleukin-6, tumour necrosis factor-alpha and interferon-gamma in the diagnosis and outcome correlation of tuberculous effusion.
Wong CF; Yew WW; Leung SK; Chan CY; Hui M; Au-Yeang C; Cheng AF
Respir Med; 2003 Dec; 97(12):1289-95. PubMed ID: 14682409
[TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of tuberculous pleurisy by measurement of cytokine concentrations in pleural effusion.
Ogawa K; Koga H; Hirakata Y; Tomono K; Tashiro T; Kohno S
Tuber Lung Dis; 1997; 78(1):29-34. PubMed ID: 9666960
[TBL] [Abstract][Full Text] [Related]
15. [Values of TNF, IL-8, sICAM-1 and CD11b/CD18 in benign and malignant pleural effusions].
Huang Y; Xie C
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):35-9. PubMed ID: 11802937
[TBL] [Abstract][Full Text] [Related]
16. T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions.
Okamoto M; Hasegawa Y; Hara T; Hashimoto N; Imaizumi K; Shimokata K; Kawabe T
Chest; 2005 Dec; 128(6):4030-5. PubMed ID: 16354877
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of soluble interleukin 2 receptor alpha in the pleural fluid].
Ni SS; Gao ZL
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):81-2, 123. PubMed ID: 8221956
[TBL] [Abstract][Full Text] [Related]
18. Cytokine content in pleural effusion. Comparison between tuberculous and carcinomatous pleurisy.
Shimokata K; Saka H; Murate T; Hasegawa Y; Hasegawa T
Chest; 1991 May; 99(5):1103-7. PubMed ID: 1902158
[TBL] [Abstract][Full Text] [Related]
19. The comparison of pleural fluid TNF-α levels in tuberculous and nontuberculous pleural effusion.
Damayanti N; Yudhawati R
Indian J Tuberc; 2020 Jan; 67(1):98-104. PubMed ID: 32192626
[TBL] [Abstract][Full Text] [Related]
20. Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions.
Wang M; Zhang Z; Wang X
Clinics (Sao Paulo); 2014; 69(12):799-803. PubMed ID: 25627990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
